, A, representa<ve, western, blot, of, α>sarcoglycan, is, included, , showing, that, α>sarcoglycan, levels, remain, unaltered, in, CAPN3>sh, treated, myotubes, compared, to, NS>sh, controls .,, Figure' S7.,Similar,matura<on,levels,in,C2C12,and,LHCN>M2,were,observed,in,control,(NS>shRNA),and, calpain,3>deficient,myotubes,(Capn3>sh;,CAPN3>sh),,as,determined,by,(A,'B)'quan<fica<on,of,myotube, width,,(C),,immunocytochemistry,(D),crea<ne,kinase,ac<vity,,or,(E),mRNA,levels,of,crea<ne,kinase,(CK),, dihydropyridine,receptor,(DHPR),and,dystrophin,(DYS)., Assays, in, B9E'were, performed, in, human, LHCN> M2, myotubes, as, described, in, the, material, and, methods, sec<on., No, significant, differences, were, observed, in, any, of, these, assays, between, CAPN3>deficient, and, control, myotubes .,A,'B)'Myotube,width, was,determined,in,10,representa<ve,myotubes,from,each,culture.,C)'Immunocytochemistry,of,NS> shRNA,and,CAPN3>deficient,myotubes,show,similar,myotube,matura<on,levels.,Myosin,heavy,chain, expression,(MyHC),,nuclei,number,and,localiza<on,(DAPI),,and,aggrega<on,of,acetylcholine,receptors, (Texas,red,conjugated,α>bungarotoxin,,BTX),are,commonly,used,markers,of,myotube,matura<on., ,Scale,bar=,50,μm.,A9E)',Data,are,expressed,as,mean,±,SEM,of,at,least,N=3,different,experiments.,, , ,was, measured,with,the,ra<ometric,fluorochrome,Fura>2AM,in,the,presence,of,2, mM,extracellular,Ca 2+ ., No, difference, was, observed, between, control, (NS>sh), and, Capn3>deficient, myotubes, (Capn3>sh) ., Numbers, of, myotubes, recorded, are, shown, in, the, graph, (n=6, experiments) ., Protein,levels,of,parvalbumin,were,found,increased,in,Capn3>shRNA , mouse,myotubes,compared,to,NS,controls,(174,±,13.10%,vs.,100,±,6.01%;,n=3,, *P<0.05).,No,parvalbumin,was,detected,in,human,LHCN>M2., Figure' S9,, Figure S10 . Cross sections of human muscles co-immunostained for SERCA1 and SERCA2. Overall SERCA2 levels appear reduced in the LGMD2 sample, mostly in the central region of the fibres. Note the higher accumulation of SERCA2 near the sarcolemma, in some fibres (arrows). A fraction of slow fibres of the LGMD2A patient co-express SERCA2 and low levels of SERCA1 (asterisks). Scale bar: 50 µm. ! Figure S11 . Prediction of protein-protein interaction between CAPN3 and SERCA1 using PRISM 2.0 webserver. ! Upper panel shows protein data bank 3D structures of CAPN3 PEF domain (blue, 4okh) and SERCA1 (red, 3tlm) and their protein-protein interface. Lower panel lists the 20 interface residues contacts between CAPN3 and SERCA1. According to the PDB numbering, the following set of helices is involved in the interaction: SERCA1 helix 4 (3 residues), helix 40 (9 residues) and helix 42 (3 residues); CAPN3 helix 18 (2 residues), helix 21 (7 residues) and helix 23 (4 residues).! Figure'S11,, Table S1 . Primer sequences used for real-time qPCR analysis on human LHCN-M2 myotubes. !
